ACTIVE

EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result10,3 M €+54,6 %over 1 year

Revenue52,3 M €+1,8 %over 1 year

Equity90,4 M €+12,9 %over 1 year

Workforce220,3 ETP+1,1 %over 1 year

Identity

Source · BCE/KBO

EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI is a International non-profit organization incorporated in 1963. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Woluwe-Saint-Lambert. It employs on average 220,3 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0408.292.992
Incorporation: 18/06/1963
Legal form: International non-profit organization
Registered office: Avenue Emmanuel Mounier 83 box 11
1200 Woluwe-Saint-Lambert · BruxellesSee on map
Latest accounts: 31/12/2025
Average workforce: 220,3 ETP

Activities (NACE)

72109Research and experimental development on natural sciences and engineering· main 72190Other research and experimental development on natural sciences and engineering 73100Advertising

Joint committees (3)

Contacts

4 public details availableLog in to view

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 18 filings

Trend over 6 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	52,3 M €	+1.8%	51,3 M €	+8.8%	47,2 M €	+34.5%	35,1 M €	-2.9%	36,1 M €
EBITDA	12,1 M €	+31.5%	9,2 M €	+26.4%	7,3 M €	+587%	-1,5 M €	-261%	928,9 k €
Operating result	11 M €	+27.4%	8,7 M €	+28.8%	6,7 M €	+396%	-2,3 M €	-760%	344 k €
Net result	10,3 M €	+54.6%	6,7 M €	+7.3%	6,2 M €	+237%	-4,5 M €	-361%	-985 k €
Balance sheet
Equity	90,4 M €	+12.9%	80,1 M €	+9.1%	73,4 M €	+9.3%	67,2 M €	-6.3%	71,7 M €
Total assets	135,2 M €	-1.7%	137,5 M €	+5.8%	130 M €	+6.5%	122,1 M €	+1.0%	120,8 M €
Cash	6,6 M €	-21.6%	8,4 M €	+14.1%	7,3 M €	-76.1%	30,8 M €	-55.1%	68,6 M €
Debts	43,7 M €	-23.3%	57 M €	+3.0%	55,3 M €	+6.9%	51,7 M €	+8.2%	47,8 M €
Other
Workforce	220,3 ETP	+1.1%	217,8 ETP	-5.6%	230,7 ETP	-2.2%	235,8 ETP	+9.2%	216,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 250 M€ and 500 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

12 active · 22 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Diego du Monceau	Director18/06/2021 → 27/06/2027
Benjamin Besse	Director18/06/2021 → 27/06/2027
Caroline Artis	Director27/06/2024 → 27/06/2027
Denis Lacombe	Personne déléguée à la gestion journalière18/06/2021 → 27/06/2027Mandate15/06/2012 → 2013 accountsended
Elizabeth Eisenhauer	Director18/06/2021 → 27/06/2027
Etienne Brain	Director18/06/2021 → 27/06/2027
Mieke Van Hemelrijck	Director18/06/2021 → 27/06/2027
Roberto Salgado	Director27/06/2024 → 27/06/2027
Vassilis Golfinopoulos	Personne déléguée à la gestion journalière18/06/2021 → 27/06/2027
Wilhelmina van der Graaf	Chairman of the board of directors11/02/2022 → 27/06/2027
Anne-Marie Dingemans	Director27/06/2024 → 27/06/2027
Jean-Pascal Henry Machiels	Director27/06/2024 → 27/06/2027

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Bertrand Tombal	Director11/02/2022 → 2024 accounts
Michael Weller	Director28/06/2024 → 2024 accounts
Guy Beniada	Director18/06/2022 → 2023 accounts

Other companies at this address

Avenue Emmanuel Mounier 83 1200 Woluwe-Saint-Lambert

Company	CBE no.
EBC Council● Active	0435.442.995
EORTC Cancer Research Fund● Active	0416.340.628
EUROPEAN SOCIETY OF SURGICAL ONCOLOGY - SOCIETE EUROPEENNE D'ONCOLOGIE CHIRURGICALE - EUROPESE GEMEENSCHAP VOOR CHIRURGISCHE ONCOLOGIE● Active	0478.925.226
ILSI Europe● Active	0432.722.740

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/06/2026	01/07/2025	01/07/2024	28/08/2023	23/06/2022	29/06/2021
General meeting	26/06/2026	27/06/2025	28/06/2024	25/08/2023	17/06/2022	18/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 18 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	26/06/2026	29/06/2026	French	PDF
Full model	31/12/2024	27/06/2025	01/07/2025	French	PDF
Full model	31/12/2023	28/06/2024	01/07/2024	French	PDF
Full model	31/12/2022	25/08/2023	28/08/2023	French	PDF
Full model	31/12/2021	17/06/2022	23/06/2022	French	PDF
Full model	31/12/2020	18/06/2021	29/06/2021	English	PDF
Full model	31/12/2020	18/06/2021	29/06/2021	French	PDF
Full model	31/12/2019	04/09/2020	22/09/2020	English	PDF
Full model	31/12/2019	04/09/2020	22/09/2020	French	PDF
Full model	31/12/2018	25/06/2019	02/08/2019	English	PDF
Full model	31/12/2018	25/06/2019	28/06/2019	French	PDF
Full model	31/12/2017	22/06/2018	27/06/2018	English	PDF
Full model	31/12/2017	22/06/2018	26/06/2018	French	PDF
Full model	31/12/2016	23/06/2017	30/06/2017	English	PDF
Full model	31/12/2016	23/06/2017	29/06/2017	French	PDF
Full model	31/12/2015	24/06/2016	11/07/2016	French	PDF
Full model	31/12/2014	25/06/2015	02/07/2015	French	PDF
Full model	31/12/2013	20/06/2014	01/07/2014	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 M€ and 500 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

12 active · 22 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Diego du Monceau	Director18/06/2021 → 27/06/2027
Benjamin Besse	Director18/06/2021 → 27/06/2027
Caroline Artis	Director27/06/2024 → 27/06/2027
Denis Lacombe	Personne déléguée à la gestion journalière18/06/2021 → 27/06/2027Mandate15/06/2012 → 2013 accountsended
Elizabeth Eisenhauer	Director18/06/2021 → 27/06/2027
Etienne Brain	Director18/06/2021 → 27/06/2027
Mieke Van Hemelrijck	Director18/06/2021 → 27/06/2027
Roberto Salgado	Director27/06/2024 → 27/06/2027
Vassilis Golfinopoulos	Personne déléguée à la gestion journalière18/06/2021 → 27/06/2027
Wilhelmina van der Graaf	Chairman of the board of directors11/02/2022 → 27/06/2027
Anne-Marie Dingemans	Director27/06/2024 → 27/06/2027
Jean-Pascal Henry Machiels	Director27/06/2024 → 27/06/2027

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Bertrand Tombal	Director11/02/2022 → 2024 accounts
Michael Weller	Director28/06/2024 → 2024 accounts
Guy Beniada	Director18/06/2022 → 2023 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates21/09/2026
NOMINATION DU COMMISSAIRE
PDF
Other15/09/2026
MODIFICATION DU CONSEIL D'ADMINISTRATION
PDF
Other08/09/2026
Modification des statuts
PDF
Mandates05/02/2026
DEMISSIONS, NOMINATIONS
PDF
Mandates08/10/2025
DEMISSIONS, NOMINATIONS
PDF
Other30/09/2024
DIVERS
PDF
Mandates26/08/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates26/08/2024
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation1963

Name

Registered office

Annual accounts

Filings6 filings

Mandates

Diego du Monceau

Anne-Marie Dingemans

Mieke Van Hemelrijck

Elizabeth Eisenhauer

Etienne Brain

Vassilis Golfinopoulos

Denis Lacombe

Wilhelmina van der Graaf

Caroline Artis

Roberto Salgado

Benjamin Besse

Jean-Pascal Henry Machiels

and 22 more mandates

19661967196819691970197119721973197419751976197719781979198019811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

EORTC

Avenue Emmanuel Mounier 83 bte 11, 1200 Woluwe-Saint-Lambert

Director

Personne déléguée à la gestion journalière

Chairman of the board of directors

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Avenue Emmanuel Mounier 83 bte 11, 1200 Woluwe-Saint-LambertCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00211031

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANICurrent		CBE
EORTC	accounts 2022 → 2025	Accounts 2025 · 2026-00211031
European Organisation for Research and Treatment of Cancer	accounts 2021	Accounts 2021 · 2022-20084767
EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI	accounts 2013	Accounts 2013 · 2014-23700536

Events

01/06/2026
nominationB. Besse · Prochain Président de l'EORTC
01/06/2026
nominationBenjamin Besse · Président (President-elect)
2025
Annual accounts 202510,3 M €↑
19/03/2025
nominationVassilis Golfinopoulos · Chief Medical Officer
2024
Annual accounts 20246,7 M €↑
28/06/2024
reconductionWilhelmina (Winette) van der Graaf · Présidente
28/06/2024
nominationEtienne Brain · Secrétaire général
28/06/2024
nominationDenis Lacombe · Chief Executive Officer (CEO)
28/06/2024
nominationVassilis Golfinopoulos · Directeur Headquarters
2023
Annual accounts 20236,2 M €↑
16/06/2023
nominationEY Reviseurs d'Entreprises SCCRL · commissaire
2022
Annual accounts 2022-4,5 M €↓
2022
Name changeEORTC
2021
Annual accounts 2021-985 k €↓
2021
Name changeEuropean Organisation for Research and Treatment of Cancer
2013
Annual accounts 20131,7 M €
18/06/1963
IncorporationInternational non-profit organization

EUROPESE ORGANISATIE VOOR ONDERZOEK EN BEHANDELING VAN KANKER - ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANI

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events